Published in Toxicol Sci on August 13, 2007
Epigenetics and environmental chemicals. Curr Opin Pediatr (2009) 2.83
RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect (2008) 1.95
Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells (2007) 1.32
Epigenetics meets endocrinology. J Mol Endocrinol (2011) 1.30
miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci (2008) 1.21
Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci (2008) 1.13
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One (2012) 1.00
Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicol Sci (2009) 0.92
Endocrine disruption of the epigenome: a breast cancer link. Endocr Relat Cancer (2014) 0.90
Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver. Drug Metab Dispos (2008) 0.90
Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression. PLoS One (2012) 0.87
The emerging role of microRNAs in drug responses. Curr Opin Mol Ther (2010) 0.85
The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol (2014) 0.84
LTR: Linear Cross-Platform Integration of Microarray Data. Cancer Inform (2010) 0.81
Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage. Mol Cell Pharmacol (2011) 0.80
Effects of short-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on microRNA expression in zebrafish embryos. Toxicol Appl Pharmacol (2012) 0.78
Back to the future: transgenerational transmission of xenobiotic-induced epigenetic remodeling. Epigenetics (2015) 0.78
Role of microRNAs and DNA Methyltransferases in Transmitting Induced Genomic Instability between Cell Generations. Front Public Health (2014) 0.77
Exposure to diethylstilbestrol during pregnancy modulates microRNA expression profile in mothers and fetuses reflecting oncogenic and immunological changes. Mol Pharmacol (2015) 0.76
RDX and miRNA Expression in B6C3F1 Mice. Environ Health Perspect (2009) 0.75
International network of cancer genome projects. Nature (2010) 20.35
Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem (2004) 4.10
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics (2011) 3.68
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res (2006) 2.50
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest (2009) 2.43
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol (2013) 2.32
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol (2007) 2.10
Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol (2005) 2.02
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell (2009) 1.92
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res (2005) 1.89
Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci U S A (2010) 1.71
Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin Cancer Res (2006) 1.65
Unsupervised pattern recognition: an introduction to the whys and wherefores of clustering microarray data. Brief Bioinform (2005) 1.64
Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods (2013) 1.64
Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis. J Mol Diagn (2011) 1.57
NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics (2012) 1.45
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair. Clin Cancer Res (2013) 1.45
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer. J Pathol (2012) 1.42
Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 1.37
Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol (2006) 1.34
Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor. Toxicol Appl Pharmacol (2005) 1.33
Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver. BMC Genomics (2011) 1.23
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics (2008) 1.18
Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. Cancer Res (2008) 1.17
Systematic evaluation of medium-throughput mRNA abundance platforms. RNA (2012) 1.15
Evaluation of various housekeeping genes for their applicability for normalization of mRNA expression in dioxin-treated rats. Chem Biol Interact (2006) 1.14
Optimization of experimental design parameters for high-throughput chromatin immunoprecipitation studies. Nucleic Acids Res (2008) 1.12
In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J Proteome Res (2011) 1.11
Polymorphisms in the human AH receptor. Chem Biol Interact (2002) 1.11
Microarray analysis of the developing cortex. J Neurobiol (2006) 1.11
CUL7 is a novel antiapoptotic oncogene. Cancer Res (2007) 1.09
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics (2012) 1.08
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer. J Pathol (2012) 1.07
Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting. Biochem Biophys Res Commun (2004) 1.06
Toward better benchmarking: challenge-based methods assessment in cancer genomics. Genome Biol (2014) 1.05
Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma. Blood (2010) 1.05
Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction. Genome Med (2013) 1.05
Epigenetic markers of prostate cancer in plasma circulating DNA. Hum Mol Genet (2012) 0.99
PUNS: transcriptomic- and genomic-in silico PCR for enhanced primer design. Bioinformatics (2004) 0.99
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PLoS One (2013) 0.98
Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2). Mol Pharmacol (2010) 0.98
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Mol Cancer Ther (2007) 0.97
Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. Front Neuroendocrinol (2010) 0.97
Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats. Arch Toxicol (2008) 0.93
Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicol Sci (2009) 0.92
TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis (2004) 0.92
Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. Toxicol Appl Pharmacol (2010) 0.91
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells. Breast Cancer Res Treat (2013) 0.91
Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics (2010) 0.90
Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver. Drug Metab Dispos (2008) 0.90
Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Mol Cell Biol (2012) 0.89
Identification of genes responsive to PFOS using gene expression profiling. Environ Toxicol Pharmacol (2005) 0.89
dbZach: A MIAME-compliant toxicogenomic supportive relational database. Toxicol Sci (2006) 0.89
Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity. Toxicol Appl Pharmacol (2011) 0.88
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus. Kidney Int (2013) 0.88
Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain. Biochem Biophys Res Commun (2004) 0.88
Differential expression profiling of the hepatic proteome in a rat model of dioxin resistance: correlation with genomic and transcriptomic analyses. Mol Cell Proteomics (2006) 0.87
Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity. BMC Genomics (2014) 0.87
Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants. Int J Cancer (2013) 0.87
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer. PLoS One (2013) 0.86
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer. Cancer Med (2013) 0.86
Genome-wide gene expression profiling of stress response in a spinal cord clip compression injury model. BMC Genomics (2013) 0.86
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer. Radiother Oncol (2012) 0.86
Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin. Genes Chromosomes Cancer (2014) 0.85
Genome-wide effects of acute progressive feed restriction in liver and white adipose tissue. Toxicol Appl Pharmacol (2008) 0.85
Aryl hydrocarbon receptor splice variants in the dioxin-resistant rat: tissue expression and transactivational activity. Mol Pharmacol (2007) 0.84
Bone resorption by aryl hydrocarbon receptor-expressing osteoclasts is not disturbed by TCDD in short-term cultures. Life Sci (2005) 0.84
Identifying gene locus associations with promyelocytic leukemia nuclear bodies using immuno-TRAP. J Cell Biol (2013) 0.84
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents. Int J Cancer (2010) 0.83
Quantitative real-time reverse transcription-PCR analysis reveals stable and prolonged neurotoxin cluster gene activity in a Clostridium botulinum type E strain at refrigeration temperature. Appl Environ Microbiol (2008) 0.83
MYC phosphorylation at novel regulatory regions suppresses transforming activity. Cancer Res (2013) 0.83
Identification of aryl hydrocarbon receptor binding targets in mouse hepatic tissue treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2011) 0.82
Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst (2010) 0.81
Teneurin C-terminal associated peptide (TCAP)-1 modulates dendritic morphology in hippocampal neurons and decreases anxiety-like behaviors in rats. Physiol Behav (2011) 0.81